A Phase I, Single Centre, Open, Randomised, Parallel Study to Evaluate the Pharmacokinetics and Tolerability of Multiple Doses of Eslicarbazepine Acetate and Oxcarbazepine in Healthy Subjects
Phase of Trial: Phase I
Latest Information Update: 31 Dec 2014
At a glance
- Drugs Eslicarbazepine acetate (Primary) ; Oxcarbazepine (Primary)
- Indications Epilepsy; Neuropathic pain; Partial epilepsies
- Focus Pharmacokinetics
- Sponsors Bial
- 14 Apr 2011 Results presented at the 63rd Annual Meeting of the American Academy of Neurology.
- 05 Dec 2010 Data were presented at the 2010 annual meeting of the American Epilepsy Society (AES), according to a Sunovion Pharmaceuticals media release.
- 14 May 2009 New trial record